Tobi L. Millrood, a partner, joined the firm to chair its Mass Tort Department. Millrood is a national leader in the trial bar and has 25 years of complex litigation experience, including in court-appointed leadership positions, and has won a number of major jury verdicts in complex litigation. His focus is on pharmaceutical, medical device and complex personal injury litigation.

Millrood is past president of the world’s largest trial bar, the American Association for Justice (AAJ), where he completed his term in July 2021 and currently serves as Immediate Past President. As a result of his leadership within AAJ, Millrood has received numerous awards including Distinguished Service, Heavy Lifting and the prestigious President’s Award in 2015.

In addition, Millrood has won many accolades and enjoys a national reputation in the field of mass torts. He has been named among the best attorneys in Pennsylvania by Super Lawyers.

Among his numerous highlights in the field of prescription drug and medical device litigation is his perseverance and success against Wyeth, Pfizer and numerous other Fortune 100 companies in the landmark Hormone Therapy litigation. In 2002, Millrood was the first in the nation to file a Hormone Therapy lawsuit and he dedicated the next twelve years to the litigation, serving as Plaintiffs’ Lead Liaison Counsel for the matter in Philadelphia Common Pleas Court, presiding over thousands of cases.

He also served on the plaintiffs’ executive committee In Re Prempro Products Liability, and was chair of the AAJ Hormone Therapy Litigation Group. Millrood tried four hormone therapy cases, winning jury verdicts in all four, including those of $72.6 million and $34.3 million.

He also played a major contributing role in critical  appellate victories in the litigation, ranging from the state courts of Pennsylvania and Minnesota, to the U.S. Eighth Circuit. He also served in numerous court-appointed leadership positions in other pharmaceutical and medical device cases, including co-Lead counsel in In re Zofran (Ondansetron) Products Liability Litigation MDL 2657, and as co-lead counsel in In re Zimmer Nexgen Knee Products Liability Litigation, MDL 2272.

Millrood was named a co-lead counsel in Pennsylvania opioid litigation, Del. Cty. vs Purdue Pharma, et al. Working in combination with leaders both locally and nationwide, Millrood served on a leadership team that produced a settlement that can bring more than $1 billion to Pennsylvania municipalities and communities devastated by the opioid epidemic.

In addition, he has served in other court-appointed leadership positions, including the Plaintiffs’ Steering Committees of In re Stryker Rejuvenate Hip Stem and ABG Modular Hip Litigation, Bergen County, N.J., and In re Consolidated Fresenius Cases in Superior Court in Massachusetts, where in both he was also appointed as Discovery Chair.

Millrood is often called upon within mass tort litigation for his strategic planning and discovery architecture. He is a frequent speaker at various seminars on the topics of Mass Tort Litigation, Expert Witnesses, Direct and Cross-Examination, Closing and Rebuttal at Trial, the Ethics of Settling Mass Tort Cases, Trial Strategies and Electronic Discovery.

Millrood has testified before the Federal Civil Rules Committee on proposed rule changes and has authored numerous comments to the Rules Committee and Subcommitee on MDL litigation. He is an invited lecturer at University of Pennsylvania Carey Law School and an invited trial team coach at the Tulane Law School. Earlier in his career,

Millrood garnered several notable achievements and verdicts, including serving as co-counsel in a $22 million medical malpractice verdict, among the largest in state history at that time. Millrood is a member of the Pennsylvania Association for Justice Board of Governors and the Philadelphia Trial Lawyers Board of Directors. He is admitted to practice in Pennsylvania, New Jersey, the federal District of New Jersey, the U.S. Eastern District of Pennsylvania, the Court of Federal Claims and the U.S. Third Circuit.

Millrood earned his bachelor’s degree from Tulane University and his law degree from the University of Tulsa College of Law.